Spots Global Cancer Trial Database for he4
Every month we try and update this database with for he4 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer | NCT04826029 | Advanced Stage ... Advanced Stage ... Advanced Stage ... | Standard strate... Follow-up strat... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| REM (Risk Of Endometrial Malignancy) | NCT01830192 | Endometrial Dis... | Training set VERIFICATION SE... | 45 Years - 80 Years | Campus Bio-Medico University | |
| Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor | NCT03779399 | Ovarian Cancer Borderline Ovar... Benign Ovarian ... Unexplained Inf... | Assessment of p... | 18 Years - 75 Years | Medical University of Lublin | |
| Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | NCT00987649 | Adnexal Mass Ovarian Cancer | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| Serum Biomarker HE4 During IVF Treatment | NCT01576744 | IVF Treatment Human Epididyma... | 27 Years - 39 Years | Turku University Hospital | ||
| HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding | NCT04867109 | Endometrial Neo... Postmenopause Uterine Hemorrh... Cancer Biomarke... CA 125 Antigen | Patients with P... CA125 and HE4 a... | 18 Years - | Nantes University Hospital | |
| Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass | NCT02109367 | Ovarian Cancer | 30 Years - | Southern Illinois University | ||
| Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer | NCT04826029 | Advanced Stage ... Advanced Stage ... Advanced Stage ... | Standard strate... Follow-up strat... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| HE4 as a Relapse Biomarker in Ovarian Cancers | NCT02595281 | Ovarian Carcino... | Experimental ar... | 18 Years - | Institut de Cancérologie de Lorraine | |
| Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis | NCT03193671 | Ovarian Neoplas... Diagnoses Disea... Biomarkers Algorithms | Diagnosis | 18 Years - | Göteborg University | |
| Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer | NCT04826029 | Advanced Stage ... Advanced Stage ... Advanced Stage ... | Standard strate... Follow-up strat... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Transforming Ovarian Cancer Diagnostic Pathways | NCT06129968 | Ovarian Cancer | - | Sandwell & West Birmingham Hospitals NHS Trust | ||
| HE4 as a Relapse Biomarker in Ovarian Cancers | NCT02595281 | Ovarian Carcino... | Experimental ar... | 18 Years - | Institut de Cancérologie de Lorraine | |
| Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | NCT00987649 | Adnexal Mass Ovarian Cancer | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| Serum Biomarker HE4 During IVF Treatment | NCT01576744 | IVF Treatment Human Epididyma... | 27 Years - 39 Years | Turku University Hospital | ||
| Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis | NCT03193671 | Ovarian Neoplas... Diagnoses Disea... Biomarkers Algorithms | Diagnosis | 18 Years - | Göteborg University | |
| REM (Risk Of Endometrial Malignancy) | NCT01830192 | Endometrial Dis... | Training set VERIFICATION SE... | 45 Years - 80 Years | Campus Bio-Medico University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
